Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 3 | 0 |
| Jan 2026 | 0 | 4 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 3 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 29, 2024 Filed May 3, 2024 22:32 UTC |
SMITH J. JEFFERSONChief Research Officer
|
GrantCommon Stock | 1,006 | $12.42 | $12,494.52 |
DisclosureSEC source: 0000950170-24-053114 · ownership.xml · nonDerivative · entry 1 SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,248 Read SEC document |
| January 23, 2024 Filed Jan 24, 2024 00:11 UTC |
SMITH J. JEFFERSONChief Research Officer
|
SaleCommon Stock | 28,000 | $0.37 | $10,360.00 |
DisclosureSEC source: 0001209191-24-002113 · doc4.xml · nonDerivative · entry 2 SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,987,269 F3 · kind: The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The reporting person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.35495 to $0.37790. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| January 22, 2024 Filed Jan 23, 2024 19:15 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
SaleCommon Stock | 21,287 | $0.36 | $7,663.32 |
DisclosureSEC source: 0001209191-24-002117 · doc4.xml · nonDerivative · entry 2 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 151,028 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 00:17 UTC |
Amoroso MichaelDirector · President and CEO
|
SaleCommon Stock | 137,390 | $0.36 | $49,460.40 |
DisclosureSEC source: 0001209191-24-002119 · doc4.xml · nonDerivative · entry 2 Amoroso Michael · CIK 0001830874 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 356,433 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on March 24, 2022. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 00:13 UTC |
List AlanChief Medical Officer
|
SaleCommon Stock | 21,526 | $0.36 | $7,749.36 |
DisclosureSEC source: 0001209191-24-002115 · doc4.xml · nonDerivative · entry 2 List Alan · CIK 0001858530 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,982 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on September 10, 2021. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. Read SEC document |
| January 20, 2024 Filed Jan 23, 2024 19:15 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 59,345 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-002117 · doc4.xml · derivative · entry 3 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,655 Underlying: Common Stock · 59,345 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. F4 · derivative.exercise_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F4 · derivative.expiration_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| January 20, 2024 Filed Jan 23, 2024 19:15 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
Exercise / conversionCommon Stock | 59,345 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-002117 · doc4.xml · nonDerivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 172,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on January 20, 2024. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. Read SEC document |
| January 20, 2024 Filed Jan 24, 2024 00:19 UTC |
Kelly John AlexanderChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 116,690 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-002121 · doc4.xml · derivative · entry 2 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,310 Underlying: Common Stock · 116,690 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. F3 · derivative.exercise_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F3 · derivative.expiration_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| January 20, 2024 Filed Jan 24, 2024 00:19 UTC |
Kelly John AlexanderChief Financial Officer
|
Exercise / conversionCommon Stock | 116,690 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-002121 · doc4.xml · nonDerivative · entry 1 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 614,169 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on January 20, 2024. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. Read SEC document |
| January 20, 2024 Filed Jan 24, 2024 00:17 UTC |
Amoroso MichaelDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 266,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-002119 · doc4.xml · derivative · entry 3 Amoroso Michael · CIK 0001830874 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 533,280 Underlying: Common Stock · 266,720 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. F4 · derivative.exercise_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F4 · derivative.expiration_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| January 20, 2024 Filed Jan 24, 2024 00:17 UTC |
Amoroso MichaelDirector · President and CEO
|
Exercise / conversionCommon Stock | 266,720 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-002119 · doc4.xml · nonDerivative · entry 1 Amoroso Michael · CIK 0001830874 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 493,823 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on January 20, 2024. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. Read SEC document |
| January 20, 2024 Filed Jan 24, 2024 00:13 UTC |
List AlanChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 60,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-002115 · doc4.xml · derivative · entry 3 List Alan · CIK 0001858530 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,988 Underlying: Common Stock · 60,012 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. F4 · derivative.exercise_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F4 · derivative.expiration_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| January 20, 2024 Filed Jan 24, 2024 00:13 UTC |
List AlanChief Medical Officer
|
Exercise / conversionCommon Stock | 60,012 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-002115 · doc4.xml · nonDerivative · entry 1 List Alan · CIK 0001858530 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,508 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on January 20, 2024. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. Read SEC document |
| January 20, 2024 Filed Jan 24, 2024 00:11 UTC |
SMITH J. JEFFERSONChief Research Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 75,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-002113 · doc4.xml · derivative · entry 4 SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,985 Underlying: Common Stock · 75,015 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. F5 · derivative.exercise_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F5 · derivative.expiration_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| January 20, 2024 Filed Jan 24, 2024 00:11 UTC |
SMITH J. JEFFERSONChief Research Officer
|
Exercise / conversionCommon Stock | 75,015 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-002113 · doc4.xml · nonDerivative · entry 1 SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,015,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on January 20, 2024. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. Read SEC document |
| November 03, 2023 Filed Nov 6, 2023 17:09 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
SaleCommon Stock | 16,023 | $0.40 | $6,409.20 |
DisclosureSEC source: 0001209191-23-054552 · doc4.xml · nonDerivative · entry 2 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,970 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. F3 · shares: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. Read SEC document |
| November 03, 2023 Filed Nov 6, 2023 22:07 UTC |
Amoroso MichaelDirector · President and CEO
|
SaleCommon Stock | 125,025 | $0.40 | $50,010.00 |
DisclosureSEC source: 0001209191-23-054549 · doc4.xml · nonDerivative · entry 2 Amoroso Michael · CIK 0001830874 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 227,103 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on March 24, 2022. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. Read SEC document |
| November 02, 2023 Filed Nov 6, 2023 17:09 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 55,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-054552 · doc4.xml · derivative · entry 3 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 110,123 Underlying: Common Stock · 55,077 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. F4 · derivative.exercise_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F4 · derivative.expiration_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| November 02, 2023 Filed Nov 6, 2023 17:09 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
Exercise / conversionCommon Stock | 55,077 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-054552 · doc4.xml · nonDerivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 128,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on November 2, 2023. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. Read SEC document |
| November 02, 2023 Filed Nov 6, 2023 22:04 UTC |
Kelly John AlexanderChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 108,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-054546 · doc4.xml · derivative · entry 2 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,312 Underlying: Common Stock · 108,188 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. F3 · derivative.exercise_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F3 · derivative.expiration_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| November 02, 2023 Filed Nov 6, 2023 22:04 UTC |
Kelly John AlexanderChief Financial Officer
|
Exercise / conversionCommon Stock | 108,188 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-054546 · doc4.xml · nonDerivative · entry 1 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 497,479 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on November 2, 2023. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. Read SEC document |
| November 02, 2023 Filed Nov 6, 2023 22:07 UTC |
Amoroso MichaelDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 283,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-054549 · doc4.xml · derivative · entry 3 Amoroso Michael · CIK 0001830874 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 566,610 Underlying: Common Stock · 283,390 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. F4 · derivative.exercise_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F4 · derivative.expiration_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| November 02, 2023 Filed Nov 6, 2023 22:07 UTC |
Amoroso MichaelDirector · President and CEO
|
Exercise / conversionCommon Stock | 283,390 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-054549 · doc4.xml · nonDerivative · entry 1 Amoroso Michael · CIK 0001830874 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 352,128 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on November 2, 2023. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. Read SEC document |
| August 31, 2023 Filed Sep 5, 2023 16:16 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
GrantCommon Stock | 5,443 | $0.39 | $2,122.77 |
DisclosureSEC source: 0001209191-23-048150 · doc4.xml · nonDerivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,916 F1 · kind: These shares were acquired under the Issuer's 2019 Employee Stock Purchase Plan subsequent to the Reporting Person's Form 4 filed on June 9, 2023. Read SEC document |
| August 31, 2023 Filed Sep 5, 2023 20:15 UTC |
SMITH J. JEFFERSONChief Research Officer
|
GrantCommon Stock | 5,175 | $0.39 | $2,018.25 |
DisclosureSEC source: 0001209191-23-048145 · doc4.xml · nonDerivative · entry 1 SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,940,254 F1 · kind: These shares were acquired under the Issuer's 2019 Employee Stock Purchase Plan subsequent to the Reporting Person's Form 4 filed on June 9, 2023. Read SEC document |
| August 31, 2023 Filed Sep 5, 2023 20:15 UTC |
Kelly John AlexanderChief Financial Officer
|
GrantCommon Stock | 5,951 | $0.39 | $2,320.89 |
DisclosureSEC source: 0001209191-23-048144 · doc4.xml · nonDerivative · entry 1 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 389,291 F1 · kind: These shares were acquired under the Issuer's 2019 Employee Stock Purchase Plan subsequent to the Reporting Person's Form 4 filed on August 22, 2023. Read SEC document |
| August 18, 2023 Filed Aug 22, 2023 20:10 UTC |
Kelly John AlexanderChief Financial Officer
|
GrantCommon Stock | 90,000 | $0.48 | $43,200.00 |
DisclosureSEC source: 0001209191-23-046874 · doc4.xml · nonDerivative · entry 1 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 383,340 F1 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.47 to $0.485. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| August 18, 2023 Filed Oct 27, 2023 20:55 UTC Amendment |
Kelly John AlexanderChief Financial Officer
|
PurchaseCommon Stock | 90,000 | $0.48 | $43,200.00 |
DisclosureSEC source: 0001209191-23-053784 · doc4a.xml · nonDerivative · entry 1 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 383,340 F1 · kind: This amendment is being filed to correct the Transaction Code (as set forth in Box 3). The Form 4, as originally filed, inadvertently reported the Transaction Code as "A." F2 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.47 to $0.485. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 16:15 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
SaleCommon Stock | 13,361 | $0.75 | $10,020.75 |
DisclosureSEC source: 0001209191-23-035789 · doc4.xml · nonDerivative · entry 3 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,473 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 16:15 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 9,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035789 · doc4.xml · derivative · entry 5 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,045 Underlying: Common Stock · 9,044 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. F5 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F5 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 16:15 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 22,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035789 · doc4.xml · derivative · entry 4 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,727 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. F4 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in two equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F4 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in two equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 16:15 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
Exercise / conversionCommon Stock | 9,044 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-035789 · doc4.xml · nonDerivative · entry 2 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 81,834 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2023. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 16:15 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
Exercise / conversionCommon Stock | 22,727 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-035789 · doc4.xml · nonDerivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 72,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2023. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:20 UTC |
Barton ShaneVP & Corporate Controller
|
Exercise / conversionRestricted Stock Units · Derivative | 6,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035835 · doc4.xml · derivative · entry 2 Barton Shane · CIK 0001836297 · VP & Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,060 Underlying: Common Stock · 6,060 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. F4 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F4 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:20 UTC |
Barton ShaneVP & Corporate Controller
|
Exercise / conversionCommon Stock | 6,060 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-035835 · doc4.xml · nonDerivative · entry 1 Barton Shane · CIK 0001836297 · VP & Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2023. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. F3 · balance_after: Amount includes 20 shares that were inadvertently omitted from the Form 4 filed on March 7, 2023 by the Reporting Person. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:15 UTC |
Kelly John AlexanderChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 13,635 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035792 · doc4.xml · derivative · entry 4 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,635 Underlying: Common Stock · 13,635 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. F4 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F4 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:15 UTC |
Kelly John AlexanderChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 34,091 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035792 · doc4.xml · derivative · entry 3 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,091 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. F3 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in two substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F3 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in two substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:15 UTC |
Kelly John AlexanderChief Financial Officer
|
Exercise / conversionCommon Stock | 13,635 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-035792 · doc4.xml · nonDerivative · entry 2 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2023. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:15 UTC |
Kelly John AlexanderChief Financial Officer
|
Exercise / conversionCommon Stock | 34,091 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-035792 · doc4.xml · nonDerivative · entry 1 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 279,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2023. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:15 UTC |
SMITH J. JEFFERSONChief Research Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,872 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035790 · doc4.xml · derivative · entry 3 SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,872 Underlying: Common Stock · 4,872 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. F3 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F3 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:15 UTC |
SMITH J. JEFFERSONChief Research Officer
|
Exercise / conversionCommon Stock | 4,872 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-035790 · doc4.xml · nonDerivative · entry 1 SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,935,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2023. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. Read SEC document |
| May 04, 2023 Filed May 8, 2023 20:15 UTC |
Frankel StanleyDirector
|
GrantRestricted Stock Units · Derivative | 126,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-027927 · doc4.xml · derivative · entry 1 Frankel Stanley · CIK 0001855726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,075 Underlying: Common Stock · 126,075 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares. F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 20:15 UTC |
Germano Geno JDirector
|
GrantRestricted Stock Units · Derivative | 126,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-027922 · doc4.xml · derivative · entry 1 Germano Geno J · CIK 0001424383 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,075 Underlying: Common Stock · 126,075 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares. F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 20:15 UTC |
Buehler KevinDirector
|
GrantRestricted Stock Units · Derivative | 126,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-027926 · doc4.xml · derivative · entry 1 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,075 Underlying: Common Stock · 126,075 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares. F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 20:15 UTC |
Wadsworth Samuel C.Director
|
GrantRestricted Stock Units · Derivative | 126,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-027928 · doc4.xml · derivative · entry 1 Wadsworth Samuel C. · CIK 0001653056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,075 Underlying: Common Stock · 126,075 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares. F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 20:15 UTC |
Pire Shari LisaDirector
|
GrantRestricted Stock Units · Derivative | 126,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-027925 · doc4.xml · derivative · entry 1 Pire Shari Lisa · CIK 0001892150 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,075 Underlying: Common Stock · 126,075 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares. F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 04, 2023 Filed May 8, 2023 20:15 UTC |
Brown MelindaDirector
|
GrantRestricted Stock Units · Derivative | 126,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-027924 · doc4.xml · derivative · entry 1 Brown Melinda · CIK 0001682988 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,075 Underlying: Common Stock · 126,075 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares. F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| April 27, 2023 Filed Apr 28, 2023 20:53 UTC |
List AlanChief Medical Officer
|
SaleCommon Stock | 7,771 | $0.79 | $6,139.09 |
DisclosureSEC source: 0001209191-23-026066 · doc4.xml · nonDerivative · entry 2 List Alan · CIK 0001858530 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,496 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. Read SEC document |
| April 26, 2023 Filed Apr 28, 2023 20:53 UTC |
List AlanChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 26,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-026066 · doc4.xml · derivative · entry 3 List Alan · CIK 0001858530 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,028 Underlying: Common Stock · 26,027 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on April 26, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F4 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on April 26, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| April 26, 2023 Filed Apr 28, 2023 20:53 UTC |
List AlanChief Medical Officer
|
Exercise / conversionCommon Stock | 26,027 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-026066 · doc4.xml · nonDerivative · entry 1 List Alan · CIK 0001858530 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,267 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on April 26, 2023. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.